What is new in the profile of infective endocarditis?

被引：1
|
作者：
Duval, X. [1 ,2 ]
Hoen, B. [1 ,3 ]
机构：
[1] Hop Bichat Claude Bernard, Assoc Etud & Prevent Endocardite Infect AEPE, F-75877 Paris 18, France
[2] Univ Paris 07, Ctr Invest Clin, Hop Bichat Claude Bernard, F-75877 Paris 18, France
[3] CHU Besancon, CNRS, Serv Malad Infect & Trop, Hop St Jacques,UMR 6249, F-25030 Besancon, France
来源：
JOURNAL DES ANTI-INFECTIEUX | 2011年 / 13卷 / 03期
关键词：
Endocarditis; Incidence; Evolution; Streptococci; Staphylococci; PATIENT CHARACTERISTICS; CLINICAL SPECTRUM; 1-YEAR SURVEY; EPIDEMIOLOGY; MORTALITY; FRANCE; TRENDS;
D O I：
10.1016/j.antinf.2011.07.006
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
In industrialized countries, after the eradication of rheumatic fever, rheumatic valve diseases progressively disappeared and the proportion of post-rheumatic infective endocarditis (IE) significantly decreased. Intravenous drug use, prosthetic valves, degenerative valve sclerosis, and invasive procedures have become the most important risk factors for IE. These changes also resulted in a decreasing incidence of streptococcal IE which was compensated by in increased incidence of staphylococcal IE. (C) 2011 Published by Elsevier Masson SAS.
引用
收藏
页码：155 / 160
页数：6
相关论文
共 50 条
12345